# Hackensack University Medical Center – FDA Inspection, Sep 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/hackensack-university-medical-center/c0fe8099-d599-44e9-844c-1690f5869ab7
Source feed: FDA_Inspections

> FDA inspection 1027008 of Hackensack University Medical Center, September 29, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1027008
- Company Name: Hackensack University Medical Center
- Inspection Date: 2017-09-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1249540 - 2024-09-17
- FDA Inspection 1162878 - 2022-02-17
- FDA Inspection 1047629 - 2018-04-04
- FDA Inspection 962090 - 2016-03-10
- FDA Inspection 887607 - 2014-07-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amy-w-yan-mai/00551315-3a03-4327-ab3a-71de5c1577d4)

Company: https://www.keypedia.com/companies/hackensack-university-medical-center/e4892a14-f7eb-459b-8a97-82abf141c418

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d